Cheryl L. Willman, MD
Areas of Expertise:
Sciences, Technology & Engineering - Medicine, genomics, research, cancer.
Cheryl L. Willman, MD, is the Director and CEO of the University of New Mexico Cancer Center and a
Professor of Pathology and Internal Medicine at the UNM School of Medicine where she holds the Maurice and Marguerite Liberman Distinguished Chair in Cancer Research. She received her BA in chemistry from St. Olaf College, and her MD in 1981 from The Mayo School of Medicine. Awarded one of the first NIH Physician Scientist Awards in 1984, she completed her residency and post-doctoral training in diagnostic pathology and cancer research at the National Institutes of Health. Dr. Willman is an internationally recognized leukemia researcher, whose work now focuses on the use of comprehensive genomic technologies and next generation gene sequencing to identify novel targets for im-proved diagnosis, risk classification, and therapy, and the translation of these new targets to diagnostics, therapeutics, and clinical trials. She has published more thaan 220 peer-reviewed scientific articles in prestigious journals as well as several books and reviews, and has nine international patents granted or pending review. Dr. Willman was a founder and President of the Association of Molecular Pathology and is a member of the U.S. Department of Energy Women in Science Hall of Fame. She has received numerous public service awards, including the 16th Governor’s Award for Outstanding New Mexico Women (2001), The New Mexico Distinguished Public Service Award (2005), and the New Mexico La Estrella Award (2013).